Stay updated on Long-term Safety of KarXT in Schizophrenia Clinical Trial

Sign up to get notified when there's something new on the Long-term Safety of KarXT in Schizophrenia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-term Safety of KarXT in Schizophrenia Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Sponsor name updated to Karuna Therapeutics, Inc., a Bristol Myers Squibb company, replacing Karuna Therapeutics.
    Difference
    0.2%
    Check dated 2026-04-02T00:44:13.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.0, was added. The previous revision, v3.4.3, was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T18:04:10.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the record history, and the previous revision v3.4.2 was removed from view.
    Difference
    0.1%
    Check dated 2026-03-11T17:41:27.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    New Revision: v3.4.2 added to the history and the temporary government-funding status notice (v3.4.1) was removed; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-11T10:20:15.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Site-wide funding notice was added and the record version updated to v3.4.1, replacing v3.4.0. These are minor metadata updates and do not affect study data, eligibility, or results.
    Difference
    0.8%
    Check dated 2026-02-04T06:58:09.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The history page now shows a glossary toggle, green/red color-coded diffs, and updated version labels (No FEAR Act Data and Revision: v3.4.0), replacing the previous No FEAR Act data and Revision: v3.3.4. These are formatting and metadata changes and do not alter the core study information; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-28T05:44:50.000Z thumbnail image

Stay in the know with updates to Long-term Safety of KarXT in Schizophrenia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-term Safety of KarXT in Schizophrenia Clinical Trial page.